内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Chase William J. Officer active across 2 companies, notably Intellia Therapeutics, Inc.. Cumulatively, 18 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €861k. History available since 14 April 2023. The latest transaction was disclosed on 15 July 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Chase William J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
276 股@ US$74.36Common StockSEC:0001628280-26-048488:0
5,491 股Common StockSEC:0001628280-26-044736:0
9,200 股Common StockSEC:0001563572-26-000001:0
408 股@ US$49.790.0007% mcap5.9% 占其流量Common StockSEC:0001628280-26-025730:0
213 股@ US$97.445.2% 占其流量Common StockSEC:0001628280-26-002435:0
275 股@ US$75.525.5% 占其流量Common StockSEC:0001628280-25-045265:0
100,000 股@ US$10.03100.0% 占其流量Common StockSEC:0000950170-25-110979:0
533 股@ US$38.535.7% 占其流量Common StockSEC:0001699031-25-000158:0
8,000 股0Common StockSEC:0000950170-25-086231:0
6,082 股@ US$41.1080.2% 占其流量Common StockSEC:0001699031-25-000129:0
784 股@ US$25.946.6% 占其流量Common StockSEC:0001699031-25-000084:0
1,182 股@ US$17.587.4% 占其流量Common StockSEC:0001628280-25-001746:0
210 股@ US$13.621.0% 占其流量Common StockSEC:0001628280-24-044798:0
1,054 股@ US$14.015.0% 占其流量Common StockSEC:0001628280-24-043071:0
26,470 股0Common StockSEC:0001628280-24-030363:0
7,737 股0Common StockSEC:0000950170-24-073680:0
1,673 股0Common StockSEC:0001209191-23-037910:0
10,483 股0Common StockSEC:0000899243-23-011381:0
About Chase William J
CHASE WILLIAM J is a declarant linked to GRAIL, Inc. and Intellia Therapeutics, Inc., where he is a director. His record includes 11 filings in total, and the sampled recent filings run from 2023-04-18 to 2026-06-22, with the transaction nature shown as Attribution.